Ignite Creation Date:
2025-12-25 @ 3:52 AM
Ignite Modification Date:
2026-02-03 @ 8:33 AM
Study NCT ID:
NCT04116502
Status:
RECRUITING
Last Update Posted:
2024-11-18
First Post:
2019-09-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera
Sponsor:
University of Birmingham
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-10-25
Start Date Type:
ACTUAL
Primary Completion Date:
2028-10-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-04-01
Completion Date Type:
ESTIMATED
First Submit Date:
2019-09-09
First Submit QC Date:
None
Study First Post Date:
2019-10-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-13
Last Update Post Date:
2024-11-18
Last Update Post Date Type:
ACTUAL